Screening for Hypertensive Disorders of Pregnancy-Reference-Cited by-同舟云学术

Screening for Hypertensive Disorders of Pregnancy

Published:2023-09-19 Issue:11 Volume:330 Page:1074
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

,Barry Michael J.¹,Nicholson Wanda K.²,Silverstein Michael³,Cabana Michael D.⁴,Chelmow David⁵,Coker Tumaini Rucker⁶,Davis Esa M.⁷,Donahue Katrina E.⁸,Jaén Carlos Roberto⁹,Li Li¹⁰,Ogedegbe Gbenga¹¹,Rao Goutham¹²,Ruiz John M.¹³,Stevermer James¹⁴,Tsevat Joel⁹,Underwood Sandra Millon¹⁵,Wong John B.¹⁶

Affiliation:

1. Harvard Medical School, Boston, Massachusetts

2. George Washington University, Washington, DC

3. Brown University, Providence, Rhode Island

4. Albert Einstein College of Medicine, New York, New York

5. Virginia Commonwealth University, Richmond

6. University of Washington, Seattle

7. University of Maryland School of Medicine, Baltimore

8. University of North Carolina at Chapel Hill

9. University of Texas Health Science Center, San Antonio

10. University of Virginia, Charlottesville

11. New York University, New York, New York

12. Case Western Reserve University, Cleveland, Ohio

13. University of Arizona, Tucson

14. University of Missouri, Columbia

15. University of Wisconsin, Milwaukee

16. Tufts University School of Medicine, Boston, Massachusetts

Abstract

ImportanceHypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017.ObjectiveThe US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy.PopulationPregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension.Evidence AssessmentThe USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit.RecommendationThe USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation)

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2809680/jama_barry_2023_us_230017_1695054951.56966.pdf

Reference50 articles.

1. Gestational hypertension and preeclampsia: ACOG Practice Bulletin summary, number 222.;American College of Obstetrician and Gynecologists;Obstet Gynecol,2020

2. Hypertension at delivery hospitalization—United States, 2016-2017.;DeSisto;Pregnancy Hypertens,2021

3. Vital signs: pregnancy-related deaths, United States, 2011–2015, and strategies for prevention, 13 states, 2013–2017.;Petersen;MMWR Morb Mortal Wkly Rep,2019

4. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth.;Ananth;Am J Obstet Gynecol,2006

5. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre-eclampsia: a systematic review and meta-analysis.;Giorgione;BJOG,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for Hypertensive Disorders of Pregnancy in the US—A New Hypertensive Urgency;JAMA Internal Medicine;2023-11-01

2. Hypertension Screening in Pregnancy;JAMA;2023-09-19

3. Early Identification of Individuals at Risk for Hypertensive Disorders of Pregnancy;JAMA Network Open;2023-09-19